论文部分内容阅读
目的 探讨穿透性角膜移植术后继发性青光眼的病因及相应处理措施。方法 对145 0例 ( 15 0 0只眼 )穿透性角膜移植术后患者的资料进行回顾性分析 ,探讨其中 80例 ( 80只眼 )继发性青光眼的发生原因、时间及与原发病的关系 ,并根据不同发生原因的继发性青光眼分别行药物或手术治疗。结果 6 3只眼经药物治疗后 2或 3周眼压恢复正常。 17只眼行抗青光眼手术 ,其中 13只眼的眼压得到控制 ,4只眼眼压仍高。结论 穿透性角膜移植围手术期的正确处理能够降低继发性青光眼的发生率。根据继发性青光眼的不同病因进行相应治疗 ,效果满意
Objective To investigate the etiology and treatment of secondary glaucoma after penetrating keratoplasty. Methods The data of 145 0 cases (1500 eyes) after penetrating keratoplasty were analyzed retrospectively to investigate the causes and the time of 80 cases (80 eyes) of secondary glaucoma. Of the relationship, and according to different causes of secondary glaucoma were treated with drugs or surgery. Results The intraocular pressure returned to normal in 2 or 3 weeks after the drug treatment in 6 3 eyes. Twenty-seven eyes underwent glaucoma surgery, of which intraocular pressure was controlled in 13 eyes and intraocular pressure in 4 eyes was still high. Conclusion Perioperative treatment of penetrating keratoplasty can reduce the incidence of secondary glaucoma. According to the different causes of secondary glaucoma corresponding treatment, the effect is satisfactory